You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AMD

Showing 26 - 50 of 1,303
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Age Related Macular Degeneration Trial in Lyon (Blood samples)

Recruiting
  • Age Related Macular Degeneration
  • Blood samples
  • Lyon, France
    Service d'ophtalmologie-HOSPICES CIVILS DE LYON - Hôpital de la
Jun 9, 2022

Production of iPSC Derived RPE Cells for Transplantation in AMD

Completed
  • Age Related Macular Degeneration (AMD)
    • (no location specified)
    Apr 4, 2022

    Age-related Macular Degeneration Trial in Boston (Omega-3 fatty acids (fish oil), Vitamin D3, Vitamin D3 )

    Active, not recruiting
    Has Results
    • Age-related Macular Degeneration
    • Omega-3 fatty acids (fish oil)
    • +3 more
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jul 26, 2022

    Age-Related Macular Degeneration, Dry Age-related Macular Degeneration, Nonexudative Age-related Macular Degeneration Trial in

    Recruiting
    • Age-Related Macular Degeneration
    • +2 more
    • i-Lumen(TM) AMD
    • i-Lumen(TM) AMD Sham
    • Phoenix, Arizona
    • +2 more
    Sep 1, 2022

    Age-Related Macular Degeneration Trial in Shanghai (Krill Oil 500 MG, Olive Oil 500MG)

    Not yet recruiting
    • Age-Related Macular Degeneration
    • Krill Oil 500 MG
    • Olive Oil 500MG
    • Shanghai, China
      Shanghai General Hospital, Shanghai Jiao Tong University
    Jul 15, 2022

    Age-Related Macular Degeneration, Choroidal Neovascularization, Genetic Counseling Trial in Salt Lake City (Early disclosure,

    Completed
    • Age-Related Macular Degeneration
    • +2 more
    • Early disclosure
    • Late disclosure
    • Salt Lake City, Utah
      University of Utah John A. Moran Eye Center
    Aug 10, 2022

    s in Wet AMD in Active Smokers

    Completed
    • Wet Age-related Macular Degeneration
    • Medical Data extraction
    • Brussels, Belgium
      CHU Brugmann
    Mar 7, 2022

    Geographic Atrophy, Macular Degeneration Trial in United States (JNJ-81201887, Prednisone, Placebo)

    Recruiting
    • Geographic Atrophy
    • Macular Degeneration
    • Phoenix, Arizona
    • +3 more
    Mar 31, 2023

    Snapshot Camera for AMD

    Not yet recruiting
    • Age Related Macular Degeneration
    • adaptive optics AO-OCT/AF instrument
    • New York, New York
      New York Eye and Ear Infirmary of Mount Sinai
    May 11, 2022

    Age-Related Macular Degeneration Trial (KH631)

    Not yet recruiting
    • Age-Related Macular Degeneration
    • (no location specified)
    Dec 10, 2022

    AMD, DR Trial in Tel Aviv (NOTAL-OCT V3.0)

    Recruiting
    • AMD
    • DR
    • NOTAL-OCT V3.0
    • Tel Aviv, Israel
    • +1 more
    Aug 2, 2022

    Retinal Revascularization and Clinical Indicators of Neovascular

    Recruiting
    • Wet Macular Degeneration
    • Ophthalmic Drugs
    • Arendal, Agder, Norway
      Sorlandet Hospital HF
    Mar 3, 2022

    Neovascular Age-related Macular Degeneration

    Completed
    • Age-related Macular Degeneration (AMD)
    • East Hanover, New Jersey
      Novartis Investigative Site
    Dec 15, 2021

    Wet Age-related Macular Degeneration Trial in Boston, Worcester (Intravitreal anti-VEGF, Intravitreal AAVCAGsCD59, Oral

    Completed
    • Wet Age-related Macular Degeneration
    • Intravitreal anti-VEGF
    • +2 more
    • Boston, Massachusetts
    • +1 more
    May 24, 2022

    Following Intensive Anti-VEGF Therapy in Wet AMD

    Completed
    • Age-Related Macular Degeneration
    • Budapest, Hungary
    • +1 more
    Dec 28, 2022

    Age Related Macular Degeneration Trial in Clermont-Ferrand (T7082)

    Completed
    • Age Related Macular Degeneration
    • T7082
    • Clermont-Ferrand, France
      Wilfried Roquet
    Feb 14, 2022

    Cell Collection to Study Eye Diseases

    Recruiting
    • Retinal Disease
    • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      Ocular Adverse Events in Neovascular Agerelated Macular

      Completed
      • Age-related Macular Degeneration (AMD)
      • Aflibercept
      • +2 more
      • East Hanover, New Jersey
        Novartis Investigative Site
      Dec 15, 2021

      Geographic Atrophy Trial (BI 771716)

      Not yet recruiting
      • Geographic Atrophy
      • BI 771716
      • (no location specified)
      Aug 29, 2023

      Neovascular Age-related Macular Degeneration Trial (FT-003)

      Not yet recruiting
      • Neovascular Age-related Macular Degeneration
      • FT-003
      • (no location specified)
      Nov 21, 2022

      Neovascular Age-related Macular Degeneration

      Completed
      • Age-related Macular Degeneration (AMD)
      • East Hanover, New Jersey
        Novartis Pharmaceuticals
      Oct 19, 2021

      Ocular Adverse Events in Neovascular Age-related Macular

      Completed
      • Age-related Macular Degeneration (AMD)
      • Aflibercept
      • +2 more
      • East Hanover, New Jersey
        Novartis Investigative Site
      Dec 15, 2021

      Relapsed Adult ALL, Relapsed Adult AML Trial in Changchun (Plerixafor)

      Active, not recruiting
      • Relapsed Adult ALL
      • Relapsed Adult AML
      • Changchun, Jilin, China
        First Hospital of Jilin University
      Nov 19, 2023

      Macular Degeneration, Wet, Metamorphopsia Trial

      Recruiting
      • Macular Degeneration, Wet
      • Metamorphopsia
        • Cuneo, Piedmont, Italy
          Ospedale Santa Croce
        Sep 20, 2022

        Age-Related Macular Degeneration, Geographic Atrophy Trial in United States (smaller incision, new generation implantable

        Recruiting
        • Age-Related Macular Degeneration
        • Geographic Atrophy
        • smaller incision, new generation implantable miniature telescope (SING-IMT)
        • Pasadena, California
        • +7 more
        Aug 5, 2022